Psychomotor Disadaptation SyndromeVIR-AGENCT07026890
The Benefits of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome
A study testing Evaluation visits, Rehabilitation sessions and Virtual reality sessions in people with Psychomotor Disadaptation Syndrome, run by Centre Hospitalier Universitaire Dijon at 1 site in France.
Trial summary
Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Psychomotor Disadaptation Syndrome
- What is being tested?
- Evaluation visits, Rehabilitation sessions and Virtual reality sessions
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 16 Jul 2025to Sep 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Person who has given written consent
- Person aged ≥ 65 years;
- With a proven diagnosis of motor maladjustment syndrome;
- Hospitalised in a geriatric care unit;
- Able to understand a simple instruction and answer a closed question;
- Ability to perform the TUG within 7 days of arriving on site
Who cannot join
- Person not affiliated to or not benefiting from a social security scheme
- Person subject to a legal protection measure (curatorship, guardianship)
- Person subject to a judicial protection measure
- An adult who is incapable or unable to give consent
- Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
- Anyone with a severe visual and/or hearing impairment
Show all 14Show fewer
- Any person with a behavioural disorder (agitation, aggressiveness)
- Any person with a severe walking or balance problem that makes motor exercises unsuitable
- Anyone with a pathology, injury, wound or severe deformity to the head or cervical spine
- Any person suffering from severe vertigo, diagnosed at the discretion of the investigating doctor
- Inability to use arm for pointing
- Persons susceptible to migraines
- Non-French speakers
- Anyone with an inter-pupillary distance outside the range of possible helmet adjustments
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
CHU Dijon Bourgogne
Dijon, 21000
Mathieu GUEUGNON, 0380293571, mathieu.gueugnon@chu-dijon.fr
About this study
Official title: The Value of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome: a Randomised Controlled Trial of Mixed Efficacy and Implementation vs. Conventional Rehabilitative Care
Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems. For the majority of these patients, a stay in a geriatric medical and rehabilitation centre is necessary, enabling an objective assessment of these disorders and multi-professional care, including physiotherapists, occupational therapists and adapted physical activity teachers, aimed at restoring safe movement and motor independence. However, rehabilitation relies on traditional exercises that are limited, repetitive and sometimes far removed from everyday activities. Technological innovations such as virtual reality (VR) offer opportunities to improve care by creating immersive environments that reproduce real-life situations. VR could thus help to rehabilitate the motor problems associated with MS.
The aim of the VIR-AGE project is to study the clinical benefits of VR in the rehabilitation of hospitalised elderly people suffering from PMDS in terms of functional deficits, particularly motor deficits.
Read more
The study will take place at the Centre gériatrique Champmaillot of the CHU Dijon Bourgogne. A total of 50 patients with SPDM will take part.
The total duration of your participation is 5 weeks.
- Conditions
- Psychomotor Disadaptation Syndrome
- Being tested
- Evaluation visits, Rehabilitation sessions, Virtual reality sessions, Additional rehabilitation sessions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Evaluation visitsOther
3 assessment visits (initial (V1), intermediate (V2) and final (V3).
A series of motor assessments carried out by the physiotherapist:
- Timed Up and Go Test (TUG)
- 10 m walk test (TM10)
- Functional Reach Test (FRT)
- Minimum Motor Test (TMM)
- 10 m walk test combined with a verbal task such as naming different animals
Rehabilitation sessionsOther
Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.
Virtual reality sessionsOther
3 virtual reality sessions per week, each lasting 30 minutes.
Additional rehabilitation sessionsOther
3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions.
| Study group | Role | What they receive |
|---|---|---|
| Experimental: conventional rehabilitation + 3 virtual reality sessions | Experimental | Not described Receives: Other: Evaluation visits; Other: Rehabilitation sessions; Other: Virtual reality sessions |
| Control: conventional rehabilitation + 3 additional rehabilitation sessions | Active comparator | Not described Receives: Other: Evaluation visits; Other: Rehabilitation sessions; Other: Additional rehabilitation sessions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in 'Timed Up and Go' time between initial and final assessment
Measured: 5 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2025
- Study start16 Jul 2025
- Primary completionSep 2027 (estimated)
- Study completionSep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Psychomotor Disadaptation SyndromeStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire DijonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07026890
- Sponsor's protocol ID
- DIPANDA 2024
- Acronym
- VIR-AGE
- Status last verified
- Apr 2026
- First submitted
- 10 Jun 2025
- Last updated
- 21 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Value of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome: a Randomised Controlled Trial of Mixed Efficacy and Implementation vs. Conventional Rehabilitative Care
- ClinicalTrials.gov ID
- NCT07026890
- Acronym / sponsor ID
- VIR-AGE / DIPANDA 2024
- Conditions
- Psychomotor Disadaptation Syndrome
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire DijonUniversity, hospital or other
- Study start
- 16 Jul 2025 (actual)
- Primary completion
- Sep 2027 (estimated)
- Study completion
- Sep 2027 (estimated)
- First posted
- 18 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems. For the majority of these patients, a stay in a geriatric medical and rehabilitation centre is necessary, enabling an objective assessment of these disorders and multi-professional care, including physiotherapists, occupational therapists and adapted physical activity teachers, aimed at restoring safe movement and motor independence. However, rehabilitation relies on traditional exercises that are limited, repetitive and sometimes far removed from everyday activities. Technological innovations such as virtual reality (VR) offer opportunities to improve care by creating immersive environments that reproduce real-life situations. VR could thus help to rehabilitate the motor problems associated with MS.
The aim of the VIR-AGE project is to study the clinical benefits of VR in the rehabilitation of hospitalised elderly people suffering from PMDS in terms of functional deficits, particularly motor deficits.
The study will take place at the Centre gériatrique Champmaillot of the CHU Dijon Bourgogne. A total of 50 patients with SPDM will take part.
The total duration of your participation is 5 weeks.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental: conventional rehabilitation + 3 virtual reality sessions | Experimental | Other: Evaluation visits, Other: Rehabilitation sessions, Other: Virtual reality sessions |
| Control: conventional rehabilitation + 3 additional rehabilitation sessions | Active comparator | Other: Evaluation visits, Other: Rehabilitation sessions, Other: Additional rehabilitation sessions |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (6 listed)
- Person who has given written consent
- Person aged ≥ 65 years;
- With a proven diagnosis of motor maladjustment syndrome;
- Hospitalised in a geriatric care unit;
- Able to understand a simple instruction and answer a closed question;
Key exclusion criteria (14 listed)
- Person not affiliated to or not benefiting from a social security scheme
- Person subject to a legal protection measure (curatorship, guardianship)
- Person subject to a judicial protection measure
- An adult who is incapable or unable to give consent
- Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Evaluation visits3 assessment visits (initial (V1), intermediate (V2) and final (V3). A series of motor assessments carried out by the physiotherapist: * Timed Up and Go Test (TUG) * 10 m walk test (TM10) * Functional Reach Test (FRT) * Minimum Motor Test (TMM) * 10 m walk test combined with a verbal task such as naming different animals | Other | Control: conventional rehabilitation + 3 additional rehabilitation sessions, Experimental: conventional rehabilitation + 3 virtual reality sessions |
| Rehabilitation sessionsUsual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes. | Other | Control: conventional rehabilitation + 3 additional rehabilitation sessions, Experimental: conventional rehabilitation + 3 virtual reality sessions |
| Virtual reality sessions3 virtual reality sessions per week, each lasting 30 minutes. | Other | Experimental: conventional rehabilitation + 3 virtual reality sessions |
| Additional rehabilitation sessions3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions. | Other | Control: conventional rehabilitation + 3 additional rehabilitation sessions |
Primary outcome
Change in 'Timed Up and Go' time between initial and final assessment
Time frame: 5 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Apr 2026.
Related trials for Psychomotor Disadaptation Syndrome
Not yet recruiting
Virtual Reality Exposure Therapy (VRET) in Psychomotor Disadaptation Syndrome
Psychomotor Disadaptation Syndrome
Not yet recruiting
Effect of Muscle Strengthening on the Incidence of Psychomotor Disadaptation Syndrome in Elderly Persons
Psychomotor Disadaptation Syndrome, Post-fall Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Evaluation visits, Rehabilitation sessions and Virtual reality sessions in people with Psychomotor Disadaptation Syndrome, run by Centre Hospitalier Universitaire Dijon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 21 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Paul ORNETTI (0380293745, paul.ornetti@chu-dijon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in 'Timed Up and Go' time between initial and final assessment (time frame: 5 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2026.